Recent Insider Transactions - Enliven Therapeutics (NASDAQ: ELVN)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ELVN Enliven Therapeutics

Kintz Samuel / director, officer: PRESIDENT AND CEO

07/17/2025

Sell

$21.58

4,150

$90K

948,742

NASDAQ ELVN Enliven Therapeutics

Kintz Samuel / director, officer: PRESIDENT AND CEO

07/17/2025

Sell

$22.69

4,687

$106K

944,055

NASDAQ ELVN Enliven Therapeutics

Kintz Samuel / director, officer: PRESIDENT AND CEO

07/17/2025

Sell

$23.37

3,663

$86K

940,392

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

07/10/2025

Sell

$2.48

1,000

$2K

114,806

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

07/10/2025

Buy

$2.48

1,000

$2K

24,000

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

07/10/2025

Sell

$22.66

1,000

$23K

23,000

NASDAQ ELVN Enliven Therapeutics

Patel Anish / officer: CHIEF OPERATING OFFICER

07/07/2025

Sell

$19.75

6,362

$126K

296,947

NASDAQ ELVN Enliven Therapeutics

Patel Anish / officer: CHIEF OPERATING OFFICER

07/07/2025

Sell

$20.69

305

$6K

296,642

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/27/2025

Sell

$2.48

3,250

$8K

115,806

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/27/2025

Buy

$2.48

3,250

$8K

26,250

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/27/2025

Sell

$20.86

3,052

$64K

23,198

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/27/2025

Sell

$21.66

198

$4K

23,000

NASDAQ ELVN Enliven Therapeutics

Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER

06/20/2025

Sell

$21.40

12,500

$267K

965,188

NASDAQ ELVN Enliven Therapeutics

Kintz Samuel / director, officer: PRESIDENT AND CEO

06/17/2025

Sell

$22.08

10,502

$232K

954,890

NASDAQ ELVN Enliven Therapeutics

Kintz Samuel / director, officer: PRESIDENT AND CEO

06/17/2025

Sell

$22.75

1,998

$45K

952,892

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/13/2025

Sell

$2.48

3,000

$7K

119,056

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/13/2025

Buy

$2.48

3,000

$7K

26,000

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

06/13/2025

Sell

$22.55

3,000

$68K

23,000

NASDAQ ELVN Enliven Therapeutics

Patel Anish / officer: CHIEF OPERATING OFFICER

06/09/2025

Sell

$20.33

6,607

$134K

303,369

NASDAQ ELVN Enliven Therapeutics

Patel Anish / officer: CHIEF OPERATING OFFICER

06/09/2025

Sell

$21.16

$1K

303,309

NASDAQ ELVN Enliven Therapeutics

Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER

06/03/2025

Sell

$20.03

7,500

$150K

977,688

NASDAQ ELVN Enliven Therapeutics

Kintz Samuel / director, officer: PRESIDENT AND CEO

06/03/2025

Sell

$20.05

7,500

$150K

965,392

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

05/27/2025

Sell

$2.48

3,250

$8K

122,056

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

05/27/2025

Buy

$2.48

3,250

$8K

26,250

NASDAQ ELVN Enliven Therapeutics

Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER

05/27/2025

Sell

$16.18

3,250

$53K

23,000